Fred Hutchinson Cencer Research Center

Seattle, Washington 98109-1024

0 studies enrolling now · 2 studies all time

What they study most

Parainfluenza

Studies at this site

• A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen — Completed
• An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection — Completed